These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7520262)

  • 1. Vascular targeting and the inhibition of angiogenesis.
    Bicknell R
    Ann Oncol; 1994; 5 Suppl 4():45-50. PubMed ID: 7520262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of angiogenesis.
    Folkman J; Ingber D
    Semin Cancer Biol; 1992 Apr; 3(2):89-96. PubMed ID: 1378314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of anti tumor agents targeting angiogenesis].
    Ono M; Kuwano M
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):178-86. PubMed ID: 9030228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis and angiogenesis inhibitors in cancer.
    Giavazzi R; Taraboletti G
    Forum (Genova); 1999; 9(3):261-72. PubMed ID: 10504172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in understanding angiogenesis through molecular studies.
    Kwon M; Libutti SK
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):26-32. PubMed ID: 16377412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does improved control of tumour growth require an anti-cancer therapy targeting both neoplastic and intratumoral endothelial cells?
    Gasparini G; Harris AL
    Eur J Cancer; 1994; 30A(2):201-6. PubMed ID: 7512357
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of tumor angiogenesis.
    Sipos EP; Tamargo RJ; Weingart JD; Brem H
    Ann N Y Acad Sci; 1994 Sep; 732():263-72. PubMed ID: 7526758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis: possibilities for therapeutic interventions.
    Wynendaele W; van Oosterom AT; Pawinski A; de Bruijn EA; Maes RA
    Pharm World Sci; 1998 Dec; 20(6):225-35. PubMed ID: 9972522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Angiogenesis agents.
    Marcinkiewicz C
    Curr Pharm Des; 2007; 13(35):3543-4. PubMed ID: 18220790
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiogenesis research enjoys growth spurt in the 1990s.
    Ziegler J
    J Natl Cancer Inst; 1996 Jun; 88(12):786-8. PubMed ID: 8637041
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vascularization and perfusion of tumors as target in cancer therapy].
    Bernsen HJ; van der Kogel AJ; van Daal WA; Rijken PF
    Ned Tijdschr Geneeskd; 1997 Feb; 141(8):364-8. PubMed ID: 9157295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of tumor angiogenesis as a cancer treatment].
    Verheul HM; Bom JB; Hoekman K; Pinedo HM
    Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1549-55. PubMed ID: 10443279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis at the interface between basic and clinical research.
    Albini A; Noonan D; Santi L
    Int J Biol Markers; 1999; 14(4):202-6. PubMed ID: 10669947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis.
    Bahramsoltani M; Plendl J
    APMIS; 2007 Jan; 115(1):30-46. PubMed ID: 17223849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.
    Ranieri G; Gasparini G
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):241-53. PubMed ID: 12477290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Targeting angiogenesis in oncology].
    Fayette J; Soria JC; Armand JP
    Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical perspective of angiogenesis inhibitors].
    Radema SA; Witteveen PO; Gebbink MB; Voest EE
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiogenesis and the regulation of antitumor defense].
    Pappas NP; Hillen HF; Wagstaff J; Griffioen AW
    Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1555-9. PubMed ID: 10443280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour vasculature as a target for anticancer therapy.
    Eatock MM; Schätzlein A; Kaye SB
    Cancer Treat Rev; 2000 Jun; 26(3):191-204. PubMed ID: 10814561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular damaging agents.
    Patterson DM; Rustin GJ
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):443-56. PubMed ID: 17459681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.